Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

← Back to the feed

ORamaVR SA

History from 5 Jun 2020

UID
CHE-478.871.980
Legal form
AG
Canton
GE
Founded
5 Jun 2020
Amount raised
not in the SHAB
Lead investor
not in the SHAB
Nominal capital · CHFCHF 559k
140k279k419k559k10 Sep 2020 · CHF 104k10 Nov 2020 · CHF 109k19 Jan 2026 · CHF 559kRound announced 30 Jan 20262020202120222023202420252026
  • shares
  • privilégiées quant au produit de liquidation
  • round announced

Record

  1. Company formed

    Founded 5 Jun 2020

    SHAB HR01-1004922098 ↗
  2. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    100’000 → 103’822.55
    Shares
    10’000’000 → 10’382’255
    New shares, % of post-step shares
    3.7% (382’255 new)
    Share classes
    7’181’844 × CHF 0.01 · 3’200’411 × CHF 0.01 privilégiées quant au produit de liquidation

    Augmentation ordinaire du capital-actions porté de CHF 100'000 à CHF 103'822, 55 par l'émission de 382'255 actions de CHF 0.01, privilégiées quant au produit de liquidation, nominatives, liées selon statuts. Capital-actions: CHF 103'822, 55, entièrement libéré, divisé en 7'181'844 actions de CHF 0.01 et 3'200'411 actions de CHF 0.01 privilégiées quant au produit de liquidation, toutes nominatives, liées selon statuts.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1004976481 ↗
  3. Capital increase

    Not assessed

    Paid in cash

    Nominal capital
    103’822.55 → 108’737.80
    Shares
    10’382’255 → 10’873’780
    New shares, % of post-step shares
    4.5% (491’525 new)
    Share classes
    7’673’369 × CHF 0.01 · 3’200’411 × CHF 0.01 privilégiées quant au produit de liquidation

    Augmentation ordinaire du capital-actions porté de CHF 103'822, 55 à CHF 108'737, 80 par l'émission de 491'525 actions ordinaires de CHF 0.01, nominatives, liées selon statuts. Capital-actions: CHF 108'737, 80, entièrement libéré, divisé en 7'673'369 actions de CHF 0.01 et 3'200'411 actions de CHF 0.01 privilégiées quant au produit de liquidation, toutes nominatives, liées selon statuts.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    SHAB HR02-1005019780 ↗
  4. Capital increase

    Confirmed round

    Paid in cash and by other means

    Nominal capital
    108’737.80 → 558’537.32
    Shares
    10’873’780 → 55’853’732
    New shares, % of post-step shares
    80.5% (44’979’952 new)
    Share classes
    7’673’369 × CHF 0.01 · 48’180’363 × CHF 0.01 privilégiées quant au produit de liquidation

    Capital-actions: CHF 558'537.32, entièrement libéré, divisé en 7'673'369 actions ordinaires de CHF 0.01 et 48'180'363 actions de CHF 0.01, privilégiées quant au produit de liquidation, toutes nominatives, liées selon statuts.

    From the SHAB entry · French original, person names removed · not an official copy · full entry ↗
    • The increase is an odd amount in small-nominal shares, as priced rounds usually are.+1.0
    • The company was founded less than six years before this capital increase.+0.5
    • The company's purpose describes technology or life-sciences development.+0.5

    Classifier score 0.85 · likely-financing threshold 0.60 · not a calibrated probability

    SHAB HR02-1006543104 ↗
  5. Round announced

    matched to a capital increase · high match confidence

    Announcement ↗

Published by 8 Oct 2026